Literature DB >> 7964330

Cardiovascular risk determination: discrepancy between total cholesterol evaluation and two compound laboratory indices in Norway.

J E Berg1, A T Høstmark.   

Abstract

OBJECTIVE: To compare group classification of cardiovascular risk by two compound laboratory indices with classification according to the serum total cholesterol concentration alone.
DESIGN: Healthy employees were defined as low and high cardiovascular risk subjects according to their total cholesterol concentration or two compound indices of blood lipid components-the total cholesterol: high density lipoprotein (HDL) cholesterol ratio and an atherogenic index defined as ([total cholesterol-HDL cholesterol]*[apolipoprotein B])/([HDL cholesterol]*[apolipoprotein A-I]). Cut off values to distinguish between low and high risk subjects were as follows: total cholesterol 6.5 mmol/l, HDL cholesterol 0.9 mmol/l, apolipoprotein A = 1.8 g/l, and apolipoprotein B = 1.3 g/l. These gave total: HDL cholesterol ratio and atherogenic index cut off values of 7.2 and 4.5 respectively.
SETTING: An occupational health service in a non-manufacturing company in Norway. PARTICIPANTS: A total of 112 male and 117 female employees. The mean body mass index values were 25.6 and 23.6 kg/m2 and the mean ages 39.8 and 40.1 years in men and women respectively. Those with cardiovascular, diabetic, or renal diseases were excluded. MEAN OUTCOME MEASURES: Serum total cholesterol, HDL cholesterol, apolipoproteins A-I and B, lipid peroxidation, blood pressure, smoking, physical activity, and fruit, vegetables, and salt in the diet were determined.
RESULTS: The cut off values allocated 19%, 7%, and 40% as high risk subjects according to total cholesterol, total: HDL cholesterol, and the atherogenic index respectively. The mean age was two to four years higher in the high risk groups. Cardiovascular risk in siblings and no reported physical activity were more prevalent in those high risk groups defined by the compound indices than by total cholesterol alone, as was a high body mass index and a measure of lipid peroxidation. Grouping according to total cholesterol failed to allocate heavy smokers mainly to the high risk group. Diet variables did not demarcate clearly between indices.
CONCLUSIONS: There is considerable variability in classification into high and low risk subjects when using the total cholesterol concentration alone compared with compound risk indices. Smoking was more prevalent in the high risk groups defined by the compound indices than by total cholesterol. These findings call for caution when total cholesterol is used to estimate cardiovascular risk in epidemiological studies, and even more so at individual counselling in occupational or primary health care settings.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964330      PMCID: PMC1059980          DOI: 10.1136/jech.48.4.338

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  22 in total

1.  Environmental influences on hemostasis and thrombosis. Diet and smoking.

Authors:  G J Miller
Journal:  Ann Epidemiol       Date:  1992-07       Impact factor: 3.797

2.  Cholesterol screening programmes: how much potential benefit?

Authors:  K T Khaw; G Rose
Journal:  BMJ       Date:  1989-09-02

3.  Ten-year mortality and morbidity related to serum cholesterol. A follow-up of 3.751 men aged 40-49.

Authors:  K Westlund; R Nicolaysen
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

4.  Fibrinogen and risk of cardiovascular disease. The Framingham Study.

Authors:  W B Kannel; P A Wolf; W P Castelli; R B D'Agostino
Journal:  JAMA       Date:  1987-09-04       Impact factor: 56.272

5.  Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men.

Authors:  I Hjermann; K Velve Byre; I Holme; P Leren
Journal:  Lancet       Date:  1981-12-12       Impact factor: 79.321

6.  The Oslo study: CHD risk factors, socioeconomic influences, and intervention.

Authors:  P Leren; A Helgeland; I Hjermann; I Holme
Journal:  Am Heart J       Date:  1983-11       Impact factor: 4.749

7.  Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].

Authors:  A Sniderman; S Shapiro; D Marpole; B Skinner; B Teng; P O Kwiterovich
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

8.  Oslo Study Diet and Antismoking Trial. Results after 102 months.

Authors:  I Hjermann; I Holme; P Leren
Journal:  Am J Med       Date:  1986-02-14       Impact factor: 4.965

9.  The diet and 15-year death rate in the seven countries study.

Authors:  A Keys; A Menotti; M J Karvonen; C Aravanis; H Blackburn; R Buzina; B S Djordjevic; A S Dontas; F Fidanza; M H Keys
Journal:  Am J Epidemiol       Date:  1986-12       Impact factor: 4.897

10.  Apolipoproteins and coronary artery disease.

Authors:  B A Kottke; A R Zinsmeister; D R Holmes; R W Kneller; B J Hallaway; S J Mao
Journal:  Mayo Clin Proc       Date:  1986-05       Impact factor: 7.616

View more
  2 in total

1.  Blood lipids and endothelial function in glycogen storage disease type III.

Authors:  E Hershkovitz; A Donald; M Mullen; P J Lee; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1999-12       Impact factor: 4.982

2.  General and gender characteristics of type 2 diabetes mellitus among the younger and older age groups.

Authors:  Samir Burhanaldin Al-Mukhtar; Nabeel Najib Fadhil; Bassam Edward Hanna
Journal:  Oman Med J       Date:  2012-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.